Human Papillomavirus (HPV) Vaccine Acceptability in Hispanic Males Living on the U.S./Mexico Border

The human papillomavirus (HPV) is the most common sexually transmitted infection in the United States, and the prevalence rate of infections is approximately 79 million. Research investigating HPV vaccine acceptability has primarily focused on female populations. The current study investigates factors associated with HPV vaccine acceptability in an underrepresented population within the literature, Hispanic males. Ninety-seven male participants (M_age = 21.68 years; SD = 3.97) were recruited from a large urban university along the U.S./Mexico border to complete a 15- to 20-minute survey. More than half of the sample reported to have had a sexual experience within the past 12 months and a fifth of these participants reported that they never use protection such as condoms. Furthermore, about half of the sample reported that they did not receive the HPV vaccine or were unaware if they received the HPV vaccine. A strong correlation emerged between individual vaccine risk perceptions and family vaccine risk perceptions (r = .82; p < .001). The following factors emerged as predictors of vaccine acceptability: having recommendations from health care providers, having a family with positive attitudes toward vaccines, and having a family that perceives less risks associated with vaccines. Implications of the findings are discussed.